FDA Inspection 1241725 — Joanne Therese Finlay, M.D.

Joanne Therese Finlay, M.D. — FEI 3030418527

The FDA completed an inspection of Joanne Therese Finlay, M.D. on May 2, 2024 in Christchurch. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 2, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Christchurch (New Zealand)

Additional Details

Clinical Investigator (CI)